EUVIMEDEUVIMED entdecken
Crossref

Evaluating Antitubulin Agents at the Taxol Binding Site: Insights from Docking and Hydrophobic Enclosure Analysis

Yonatan Dillu, Umesh Yadava

BioMed and BioSci Advances · 01.03.2026 · 72-82

DOI: 10.69626/bba.2026.0072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed and BioSci Advances, online erschienen am 01.03.2026. Verfasst von Yonatan Dillu und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a complex and aggressive disease driven by uncontrolled cell growth that invades and damages healthy tissues. Effective treatment strategies aim to selectively target malignant cells while sparing normal ones. Taxol, a well-established chemotherapeutic agent, is widely used against early and metastatic breast cancer by stabilizing microtubules and thereby blocking cell division. In this study, we evaluated ninety-eight tubulin-binding compounds identified from the existing literature using molecular docking with Glide Standard Precision and Extra Precision protocols. All compounds were docked into the Taxol binding site of the β-tubulin structure, referenced as 5SYF. Our docking results identified eighteen compounds showing superior binding scores. Among these, compounds Cp_461 and Cp_248 consistently ranked within the top three across both docking methods. The interactions between these compounds and the binding site were predominantly non-covalent, involving hydrogen bonds and various hydrophobic contacts. Enrichment analysis further confirmed that XP docking is particularly effective in distinguishing active ligands from inactive ones while reducing false positive rates. These findings highlight the importance of incorporating a hydrophobic enclosure model to better capture the true binding landscape. Overall, this work provides a refined computational framework for identifying promising tubulin-targeting candidates and offers a basis for selecting lead compounds for further experimental validation.

Zitieren

APA

Dillu, Y., & Yadava, U. (2026). Evaluating Antitubulin Agents at the Taxol Binding Site: Insights from Docking and Hydrophobic Enclosure Analysis. BioMed and BioSci Advances, 72-82. https://doi.org/10.69626/bba.2026.0072

Vancouver

Dillu Y, Yadava U. Evaluating Antitubulin Agents at the Taxol Binding Site: Insights from Docking and Hydrophobic Enclosure Analysis. BioMed and BioSci Advances. 2026:72-82. doi:10.69626/bba.2026.0072

BibTeX
@article{Dillu2026,
  author = {Dillu, Yonatan and Yadava, Umesh},
  title = {Evaluating Antitubulin Agents at the Taxol Binding Site: Insights from Docking and Hydrophobic Enclosure Analysis},
  journal = {BioMed and BioSci Advances},
  year = {2026},
  pages = {72--82},
  doi = {10.69626/bba.2026.0072}
}
Kostenlos starten →